Univest
Univest
  • Markets

Alpa Labs Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

  • June 22, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Alpa Labs Stock Prediction 2026

Alpa Labs (NSE:ALPA) CMP: Rs 69.66 (2026). 52W High: Rs 110. 52W Low: Rs 46. MCap: Rs 143 Cr. P/E: 9.55. Sector: Pharmaceuticals and Healthcare. JM Financial: Neutral Rs 83. Kotak Securities: Neutr…

The Alpa Labs stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Alpa Labs share price prediction as one data point and not as a guarantee of future performance.

This article reviews every dimension of the Alpa Labs stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Analysts Predict for Alpa Labs Stock in 2026
  • Alpa Labs Company Overview
  • Alpa Labs Stock Prediction by Time Horizon
    • Short-Term Alpa Labs Stock Prediction
    • 12-Month Alpa Labs Stock Prediction
    • Long-Term Alpa Labs Stock Prediction
  • Alpa Labs Stock Forecast: Key Factors
    • US Generic Revenue
    • Domestic Formulations Growth
    • R&D Pipeline
    • EBITDA Margin
  • Alpa Labs Stock Prediction: Bull and Bear Scenarios
  • How Analysts Are Reading the Alpa Labs Stock Story
  • Key Risks to the Alpa Labs Stock Prediction
    • USFDA Regulatory Risk
    • Price Erosion in the US
    • R&D Execution Risk
    • Currency Risk
  • How to Monitor the Alpa Labs Stock Forecast
  • Conclusion
  • Frequently Asked Questions on Alpa Labs Stock Prediction 2026
    • What is the Alpa Labs stock prediction for 2026?
    • Is the Alpa Labs stock prediction bullish or bearish?
    • What is the Alpa Labs share price prediction based on fundamentals?
    • What is the long-term Alpa Labs stock prediction?
    • What are the key risks to the Alpa Labs stock prediction?
    • What does the Alpa Labs stock forecast say for 2026?
    • Where can I track the latest Alpa Labs stock prediction?

What Analysts Predict for Alpa Labs Stock in 2026

Analyst consensus on the Alpa Labs stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and Kotak Securities. All figures are sourced from publicly available research and should be verified before publishing.

Brokerage Rating Alpa Labs Stock Prediction (Rs) Updated
JM Financial Neutral Rs 83 2026
Kotak Securities Neutral Rs 77 2026
Analyst Consensus — Rs 80 2026

The analyst target range for Alpa Labs reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Alpa Labs stock forecast from the current price of Rs 69.66 may or may not be realised by end of 2026.

3 Stocks Building Serious Momentum Right Now

When Univest analysts identify high-conviction stock opportunities, investors pay attention.

Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.

  • Discover stocks investors are actively accumulating
  • High-conviction opportunities backed by research
  • Designed for the next phase of market growth

Unlock the latest Top Stock Picks now on Univest

See the Stocks →

Alpa Labs Company Overview

Alpa Laboratories is a significant player in India’s pharmaceutical industry with a presence across domestic formulations, US generics and specialty segments. The Alpa Labs stock prediction for 2026 reflects both the pipeline growth potential and regulatory risk.

Metric Value
NSE Ticker ALPA
Sector Pharmaceuticals and Healthcare
CMP Rs 69.66 (2026)
52 Week High Rs 110
52 Week Low Rs 46
Market Cap Rs 143 Cr
P/E Ratio 9.55
Alpa Labs Stock Prediction Consensus (12M) Rs 80

Alpa Labs Stock Prediction by Time Horizon

Analysts split the Alpa Labs share price prediction across time frames as near-term drivers differ materially from the long-term view.

Short-Term Alpa Labs Stock Prediction

The near-term Alpa Labs stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 69.66 are being watched closely. A short-term Alpa Labs share price prediction carries the most uncertainty of any time horizon.

12-Month Alpa Labs Stock Prediction

JM Financial targets Rs 83 (Neutral) and Kotak Securities targets Rs 77 (Neutral). Most desks refresh their Alpa Labs stock forecast within two to four weeks of each quarterly earnings print. The Alpa Labs share price prediction should be verified against the most recent analyst reports.

Long-Term Alpa Labs Stock Prediction

The long-term outlook for Alpa Labs is built on assumptions about demand recovery, margin expansion and revenue diversification in the Pharmaceuticals and Healthcare sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.

Alpa Labs Stock Forecast: Key Factors

The following four factors appear consistently in analyst research on Alpa Labs and are the primary inputs into the bull and bear case scenarios.

US Generic Revenue

US generics revenue is the most watched metric in the Alpa Labs stock forecast. USFDA approval timelines and price erosion rates directly affect the Alpa Labs share price prediction from most research desks.

Domestic Formulations Growth

Domestic formulation growth provides a stable base that supports the Alpa Labs stock prediction even when export growth faces headwinds.

R&D Pipeline

The depth and commercialization pace of the R&D pipeline is a key variable in the long-term Alpa Labs share price prediction. New product approvals are cited as catalysts for the Alpa Labs stock prediction.

EBITDA Margin

Sustained EBITDA margin expansion is typically the basis for the bullish Alpa Labs stock forecast. Margin recovery strengthens the Alpa Labs share price prediction from most research desks.

Alpa Labs Stock Prediction: Bull and Bear Scenarios

Scenario Alpa Labs Stock Prediction Key Conditions
Bull Case Rs 83 Strong execution, margin improvement, favourable macro and sector re-rating
Base Case Rs 80 Steady performance, gradual recovery, margins hold, growth on track
Bear Case Rs 46.0 Demand deterioration, margin pressure, sector de-rating and macro headwinds

The bull case Alpa Labs stock forecast of Rs 83 assumes most positive variables converge. The base case of Rs 80 is the analyst consensus and may or may not be achieved.

How Analysts Are Reading the Alpa Labs Stock Story

Analyst reviews of the Alpa Labs share price prediction highlight the company’s core strengths in Pharmaceuticals and Healthcare alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Alpa Labs is built on real business strengths set against real risks.

Key Risks to the Alpa Labs Stock Prediction

USFDA Regulatory Risk

Import alerts and warning letters from the USFDA are the most significant risks to the Alpa Labs stock prediction. A facility closure would force an immediate sharp revision to the Alpa Labs share price prediction.

Price Erosion in the US

Pricing pressure in US generics compresses the revenue per product and affects the Alpa Labs stock forecast. Aggressive price erosion pushes the Alpa Labs share price prediction toward the bear case.

R&D Execution Risk

Delays in clinical trials or approval failures affect the Alpa Labs stock prediction. The Alpa Labs share price prediction is particularly sensitive to key pipeline asset announcements.

Currency Risk

A strengthening rupee against the dollar reduces export realisation and affects the Alpa Labs stock forecast. Currency risk is embedded in conservative Alpa Labs share price prediction models.

How to Monitor the Alpa Labs Stock Forecast

Track the Alpa Labs share price prediction consensus quarterly. After every earnings release, most brokerages revise their Alpa Labs stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Alpa Labs is improving or deteriorating.

Compare the current price of Rs 69.66 with the analyst target range of Rs 83 to Rs 77. A wide target band reflects genuine uncertainty on Alpa Labs, so position size should reflect that range rather than the midpoint alone.

Review the Alpa Labs share price prediction every quarter against key business metrics for the Pharmaceuticals and Healthcare sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.

Check Live Alpa Labs Fundamentals on the Univest Screener

Conclusion

The Alpa Labs stock prediction for 2026 reflects the analyst community’s assessment of Alpa Laboratories’s competitive position, earnings trajectory and macro environment. JM Financial holds a Neutral stance with a target of Rs 83 while Kotak Securities has a Neutral rating with a target of Rs 77, giving an analyst consensus of Rs 80.

The Alpa Labs stock forecast is set against near-term risks that make the Alpa Labs share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Alpa Labs share price target changes over time is more valuable than relying on any single estimate.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Alpa Labs in real time.

Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Alpa Labs Stock Prediction 2026

What is the Alpa Labs stock prediction for 2026?

Ans. The Alpa Labs stock prediction for 2026 is based on analyst consensus from JM Financial and Kotak Securities. The consensus target is Rs 80. All estimates may or may not be achieved.

Is the Alpa Labs stock prediction bullish or bearish?

Ans. JM Financial has a Neutral rating with target Rs 83. Kotak Securities has a Neutral rating with target Rs 77. The Alpa Labs stock forecast reflects genuine analyst diversity of opinion.

What is the Alpa Labs share price prediction based on fundamentals?

Ans. The Alpa Labs share price prediction rests on the US generic pipeline, domestic growth, EBITDA margin and regulatory compliance track record. Analysts tracking Alpa Labs closely cite these as the primary drivers of the 2026 outlook.

What is the long-term Alpa Labs stock prediction?

Ans. The long-term outlook assumes Alpa Labs sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 80 is the nearest reliable anchor point.

What are the key risks to the Alpa Labs stock prediction?

Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Alpa Labs should be read alongside its risk assumptions.

What does the Alpa Labs stock forecast say for 2026?

Ans. JM Financial: Neutral target Rs 83. Kotak Securities: Neutral target Rs 77. These Alpa Labs share price prediction estimates may or may not prove accurate.

Where can I track the latest Alpa Labs stock prediction?

Ans. Track the latest analyst targets and price movements for Alpa Labs on the NSE and BSE websites and on the Univest app and screener for live data.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply